OCEAN BIOMEDICAL, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
OCEAN BIOMEDICAL, INC. (OCEA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 12.60 million shares for the 3-month period ending 2023-09-30, per its 10-Q filed 2024-04-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2024-04-15
- OCEAN BIOMEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-09-30 was 12.60M shares, a 3260.59% increase year-over-year.
- OCEAN BIOMEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-09-30 was 375.00K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|---|
| 2023-09-30 | 12.60M shares 10-Q · filed 2024-04-15 | 12.60M shares 10-Q · filed 2024-04-15 | |
| 2023-06-30 | 12.60M shares 10-Q/A · filed 2024-04-15 | ||
| 2022-09-30 | 375.00K shares 10-Q · filed 2024-04-15 | 375.00K shares 10-Q · filed 2024-04-15 | |
| 2022-06-30 | 375.00K shares 10-Q/A · filed 2024-04-15 |